Inventor · disambiguated record
Jun Wu
Also filed as: WU JUN · WU JUN-LIN
15 granted patents·17 pending applications·25 citations·filing 1996–2025
88Inventor score
Files withSALK INST FOR BIOLOGICAL STUDI6SIGNAL PHARM INC4BEIGENE SWITZERLAND GMBH3RIGEL PHARMACEUTICALS INC3SHANGHAI GENOMICS INC3
Top patents by PatentIndex Score
32 records- 0175US11959094B2Methods and compositions for genome editing in non-dividing cellsSALK INST FOR BIOLOGICAL STUDI·Filed 2023·Granted Apr 16, 2024·0 cites·20 claims
- 0274US2024409961A1Methods and compositions for genome editingSALK INST FOR BIOLOGICAL STUDI·Filed 2024·Application pending·0 cites
- 0372US8765726B2Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiationWU JUN·Filed 2007·Granted Jul 1, 2014·1 cites·2 claims
- 0472US7118854B2PAK2: modulators of lymphocyte activationRIGEL PHARMACEUTICALS INC·Filed 2001·Granted Oct 10, 2006·3 cites·12 claims
- 0565US2025075175A1Efficient derivation of stable pluripotent bovine embryonic stem cellsUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0664US2025084168A1Stable high concentration sodium chloride formulations containing pd-1 antibody and methods of use thereofBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 0764US2025034257A1Stable high concentration arginine formulations containing pd-1 antibody and methods of use thereofBEIGENE SWITZERLAND GMBH·Filed 2024·Application pending·0 cites
- 0860US7485621B2Tumor tag and the use thereofSHANGHAI GENOMICS INC·Filed 2002·Granted Feb 3, 2009·1 cites·10 claims
- 0960US2023392125A1Methods for generating formative pluripotent stem cells competent for direct primordial germ cell inductionUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1056US11674158B2Methods and compositions for genome editing in non-dividing cellsSALK INST FOR BIOLOGICAL STUDI·Filed 2017·Granted Jun 13, 2023·0 cites·15 claims
- 1156US2023073534A1Modulating tlr/nf-kb and p53 signaling pathways to enhance interspecies chimerism between evolutionaryily distant speciesUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1253US5981188AMethod for identifying agents that modulate transcription of human cytomegalovirus polymeraseSIGNAL PHARM INC·Filed 1997·Granted Nov 9, 1999·8 cites·2 claims
- 1351US2007003970A1PAK 2: modulators of lymphocyte activationRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1450US2014249347A1Use of pyridone derivatives in the prevention or treatment of tissue or organ toxicity induced by cytotoxic agents and radiationSHANGHAI GENOMICS INC·Filed 2014·Application pending·0 cites
- 1549US11225504B2Functional polypeptide and its application thereof in preparing medicament for preventing and treating pulmonary fibrosisUNIV GUANGDONG MEDICAL·Filed 2018·Granted Jan 18, 2022·0 cites·10 claims
- 1648US2025304682A1Formulations containing anti-tigit antibody and methods of use thereofBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
- 1747US7462704B2Tumor marker and its useSHANGHAI GENOMICS INC·Filed 2003·Granted Dec 9, 2008·0 cites·5 claims
- 1847US5945276AReporter cell line system for detecting cytomegalovirus and identifying modulators of viral gene expressionSIGNAL PHARM INC·Filed 1996·Granted Aug 31, 1999·8 cites·8 claims
- 1947US2023115640A1Blastocyst-like structures from extended pluripotent stem cellsSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Application pending·0 cites
- 2047US2003059924A1Cloning of a novel inhibitor of antigen-receptor signaling by a retroviral-based functional screenFiled 2002·Application pending·0 cites
- 2146US2013273649A1Culture medium for pluripotent stem cellsUNIV SOUTHERN CALIFORNIA·Filed 2013·Application pending·0 cites
- 2243US7368257B2Modulators of lymphocyte activation, Mkk3b compositions and methods of useRIGEL PHARMACEUTICALS INC·Filed 2002·Granted May 6, 2008·0 cites·10 claims
- 2343US2014248254A1The use of ache as nucleaseZHANG XUEJUN·Filed 2012·Application pending·0 cites
- 2437US2017224613A1Hydrogel compositions, methods for preparing the same and uses thereofCHONGQING MJ MEDICAL DEVICES CO LTD·Filed 2014·Application pending·0 cites
- 2535US2017283777A1Mammalian chimeric complementationSALK INST FOR BIOLOGICAL STUDI·Filed 2017·Application pending·0 cites
- 2634US12465063B2High-clarity soybean flavor peptide, preparation method therefor, and use thereofGUANGDONG TIANQI BIOTECHNOLOGY CO LTD·Filed 2020·Granted Nov 11, 2025·0 cites·6 claims
- 2734US2017205396A1Systems and methods for culturing nephron progenitor cellsSALK INST FOR BIOLOGICAL STUDI·Filed 2017·Application pending·0 cites
- 2833US9708663B2Use of SAA1B/B homozygote in the prognosis and diagnosis of liver cirrhosisWANG RONGFANG·Filed 2012·Granted Jul 18, 2017·0 cites·11 claims
- 2932US7087811B1Enhanced protein production in higher plants by N-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptideAGENCY SCIENCE TECH & RES·Filed 1998·Granted Aug 8, 2006·3 cites·15 claims
- 3030US5910411AMethod for identifying agents that modulate transcription of human cytomegalovirus polymeraseSIGNAL PHARM INC·Filed 1996·Granted Jun 8, 1999·0 cites·8 claims
- 3128US5932618AAnti-viral agents and methods relating to the use thereofSIGNAL PHARM INC·Filed 1996·Granted Aug 3, 1999·1 cites·23 claims
- 3228US2002010143A1Compositions and methods for the treatment of human cytomegalovirus infectionFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jun Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →